All In MedTech

Device Trial Radar · NCT03390907

Hybrid APC Assisted EMR for Large Colon Polyps

Hybrid APC Assisted EMR for Large Colon Polyps to Reduce Local Recurrence : A Prospective Data Collection Study

Last checked: Nov 19, 2026Latest source record: Nov 8, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

40

Actual

Start

Sep 28, 2018

Primary completion

Oct 27, 2020

Study completion Oct 27, 2020

Sponsor

Lead sponsor
Milton S. Hershey Medical CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 4, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 89 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study to evaluate and examine whether use of Hybrid Argon Plasma Coagulation (APC) as an adjunct to endoscopic mucosal resection (EMR) will reduce the risk of residual or recurrent neoplasia at 6 months. Hybrid APC is an existing FDA approved device used to assist with ablation of abnormal tissue anywhere in the GI tract.

Conditions

  • Colon Polyp
  • Colon Adenoma
  • Colon Cancer

Interventions

  • Hybrid APCDevice

    Following standard EMR Hybrid Argon Plasma Coagulation (APC) of the base and edges of the polypectomy site to fulgurate any potential microscopic residual disease.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Having Complete ResectionTime frame: 6 months post initial procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Penn State Milton S. Hershey Medical Center

    Hershey, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.